This invention provides compounds of formula I, having the structure ##STR1##

wherein R1, R4, A, and Z are as defined in the specification, or a pharmaceutically acceptable salt thereof, that are useful in treating metabolic disorders mediated by insulin resistance or hyperglycemia.

 
Web www.patentalert.com

< Oxazinocarbazoles for the treatment of CNS diseases

< Halogenobenzyl aminopropionic acid derivatives

> Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma

> Carbohydrate absorption inhibitor and method for manufacturing the same

~ 00202